Please help support CiteULike by taking part in our survey.

guhjy's profile

About me

Username:	guhjy
Name:	Jinn-Yuh Guh
Job title:	Not specified
Affiliation:	Not specified
Web page:	Not specified
Joined:	2004-11-28

What I do

Not specified

Interests

diabetic nephropathy

Recent Activity

2009-11-08

12:38: posted Systematic Review: Family History in Risk Assessment for Common Diseases.
12:37: posted IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice.
12:37: posted Proteinuria and clinical outcomes in hypertensive patients.
11:59: posted Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease.
11:38: posted The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
11:37: posted Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.
11:32: posted The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
11:32: posted Outcomes in CKD: What We Know and What We Need to Know.
11:31: posted Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure.
11:31: posted Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure.
11:27: posted The obligatory role of the kidney in long-term arterial blood pressure control: extending Guyton's model of the circulation.
11:21: posted Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
11:21: posted Treatment of liver fibrosis: clinical aspects.
10:10: posted Mineralocorticoid receptor blockers and chronic kidney disease.
10:09: posted Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
09:55: posted Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients
09:51: posted Improved outcomes in nephrotic syndrome.
09:17: posted Differential associations of dietary sodium and potassium intake with blood pressure: a focus on pulse pressure.
09:16: posted Relations between protein intake and blood pressure in Japanese men and women: the Circulatory Risk in Communities Study (CIRCS).
09:14: posted Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.
09:10: posted Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006.

2009-11-05

08:56: posted Nucleic acid aptamers for biosensors and bio-analytical applications.
08:54: posted Nucleic acid biosensors for environmental pollution monitoring.
08:50: posted Micro-electromechanical sensors in the analytical field.
08:50: posted Electrochemical biosensors at the nanoscale.
07:50: posted Nonconventional clinical trial designs: approaches to provide more precise estimates of treatment effects with a smaller sample size, but at a cost.
07:47: posted Stopping clinical trials early for benefit: impact on estimation.
07:42: posted Critically appraising randomised trials.
05:22: posted "Pragmatic" clinical trials: from whose perspective?
05:20: posted Statistical methods to analyze competing risks data: a practical review
04:26: posted Flexible survival regression modelling.
04:21: posted Flexible modeling of the cumulative effects of time-dependent exposures on the hazard.
04:18: posted Power and sample size calculations for current status survival analysis.
04:18: posted Hazard ratio funnel plots for survival comparisons.
02:09: posted Multiple imputation with large data sets: a case study of the Children's Mental Health Initiative.
02:06: posted The performance of multiple imputation for missing covariate data within the context of regression relative survival analysis.
02:03: posted Modelling time-dependent hazard ratios in relative survival: application to colon cancer.
02:03: posted A relative survival regression model using B-spline functions to model non-proportional hazards.
02:03: posted Modeling medical prognosis: survival analysis techniques.
02:02: posted Modeling survival in colon cancer: a methodological review.
02:02: posted Applying a data duplication technique in linear regression analysis of waiting time to pregnancy.
02:00: posted Dealing with competing risks: testing covariates and calculating sample size

2009-11-04

2009-11-03

2009-11-02

10:20: posted Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
10:17: posted Should we prefer different drugs to treat hypertension in older and younger adults? Practical implications of clinical trials: European perspective.
10:16: posted Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists' Collaboration and from major clinical trials.
10:15: posted Yin and yang of the plasminogen activator inhibitor.
10:15: posted Renal transplantation--demystifying the process.
10:14: posted Overview of renal transplantation.
10:13: posted The role of "metabolic memory" in the natural history of diabetes mellitus.
10:12: posted Dyslipidemia in chronic kidney disease: pathogenesis and intervention.
10:12: posted Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm.
10:11: posted Current approaches to the use of sirolimus in renal transplantation.
10:10: posted Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients.
10:10: posted Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
10:08: posted Renal transplantation in high-risk patients.
10:08: posted Immunosuppressive treatment options in renal transplantation.
10:08: posted Preventing renal transplant failure.
10:07: posted EAU guidelines on renal transplantation.
10:05: posted Renal Transplantation and Renovascular Hypertension
05:03: posted European Best Practice Guidelines for Renal Transplantation (part 1).
04:54: posted European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient.
04:54: posted European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.3.3. Long-term immunosuppression. Toxicity of immunosuppression.
04:51: posted Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
04:49: posted Pharmacology of calcineurin antagonists
04:46: posted An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients.
04:44: posted Tacrolimus: a further update of its use in the management of organ transplantation.
04:43: posted Calcineurin inhibitors in renal transplantation: what is the best option?
02:21: posted Poly(Adenosine 5'-Diphosphate-Ribose) Polymerase Inhibition Counteracts Multiple Manifestations of Experimental Type 1 Diabetic Nephropathy.
02:18: posted Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetes.
02:17: posted Diabetic nephropathy.
02:17: posted A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy.
02:16: posted The renal vascular response to diabetes.

2009-10-31

2009-10-30

04:53: posted Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
04:52: posted Hypertrophy and loss of podocytes in diabetic nephropathy.
04:52: posted [Role of dietary lipids in diabetic nephropathy]

2009-10-29

2009-10-27

09:27: posted The average rate of change for continuous time models.
08:57: posted Application of repeated-measures analysis of variance and hierarchical linear model in nursing research.
05:10: posted Bayesian methods for latent trait modelling of longitudinal data.
05:09: posted Testing multivariate mean collinearity via latent variable modelling.
05:09: posted Multilevel modelling: Beyond the basic applications.
05:03: posted Variable Selection in the Cox Regression Model with Covariates Missing at Random.
05:01: posted A discrete-time split population survival (‘cure’) model for Stata 6 or Stata 7: spsurv
04:59: posted Estimation of discrete time (grouped duration data) proportional hazards models: pgmhaz
04:51: posted The use of fractional polynomials to model interactions between treatment and continuous covariates in clinical trials
04:36: posted Recent developments in multilevel modeling, including models for binary and count responses
04:35: posted Frailty in survival analysis models (parametric frailty, parametric shared frailty, and frailty in Cox models
04:16: posted Flexible parametric alternatives to the Cox model, and more
04:07: posted Bayesian Inference in Semiparametric Mixed Models for Longitudinal Data.
03:57: posted Use of missing data methods in longitudinal studies: the persistence of bad practices in developmental psychology.
03:57: posted Making treatment effect inferences from multiple-baseline data: the utility of multilevel modeling approaches.
03:53: posted Missing inaction: the dangers of ignoring missing data.
03:53: posted Biophysical annotation and representation of CellML models
03:53: posted libAnnotationSBML: a library for exploiting SBML annotations.
03:47: posted Bias Reduction and a Solution for Separation of Logistic Regression with Missing Covariates.
03:42: posted Regression Analysis with Complex Survey Data using Stata
02:35: posted Bayesian generalized linear models and an appropriate default prior
02:35: posted Exploratory Data Analysis for Complex Models
02:34: posted Creating structured and flexible models: some open problems
02:25: posted Why we (usually) don’t worry about multiple comparisons
01:59: posted Generalized Linear and Nonlinear Mixed-Effects Models

2009-10-26

04:58: posted An introduction to latent growth curve modelling for longitudinal continuous data in dental research.
04:57: posted Incorporating Correlation for Multivariate Failure Time Data When Cluster Size Is Large.
04:56: posted On the impact of parametric assumptions and robust alternatives for longitudinal data analysis.
04:56: posted Conditional GEE for recurrent event gap times.
04:54: posted Using Generalized Estimating Equations to Analyze Longitudinal Data in Nursing Research.
04:48: posted Regression Calibration in Semiparametric Accelerated Failure Time Models.
04:46: posted On Estimating the Relationship between Longitudinal Measurements and Time-to-Event Data Using a Simple Two-Stage Procedure.
04:46: posted A frailty model approach for regression analysis of multivariate current status data.
04:45: posted Survival analysis with high-dimensional covariates.
04:44: posted Latent mixture models for multivariate and longitudinal outcomes.
04:32: posted Comparison of generalized estimating equations and quadratic inference functions using data from the National Longitudinal Survey of Children and Youth (NLSCY) database.